Publication | Open Access

Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study

Prospective Longitudinal StudyPsychiatryPsychotic DisorderPharmacologyPsychopharmacologySchizophreniaPoor Treatment ResponseSocial SciencesPharmacotherapyMedicineAltered AntioxidantPsychopathology